TY - JOUR
T1 - Correction to
T2 - A Cross-Sectional Study of Tampering in Xtampza ER, an Abuse-Deterrent Formulation of an Extended-Release Opioid, in a Treatment Center Population (Clinical Drug Investigation, (2023), 43, 3, (197-203), 10.1007/s40261-023-01248-9)
AU - Jewell, Jennifer
AU - Black, Joshua
AU - Ellis, Matthew
AU - Olsen, Heather
AU - Iwanicki, Janetta
AU - Dart, Richard
N1 - Publisher Copyright:
© 2023, The Author(s).
PY - 2023/5
Y1 - 2023/5
N2 - The article A Cross‑Sectional Study of Tampering in Xtampza ER, an Abuse‑Deterrent Formulation of an Extended‑Release Opioid, in a Treatment Center Population, written by Jennifer Jewell, Joshua Black, Matthew Ellis, Heather Olsen, Janetta Iwanicki and Richard Dart, was originally published Online First without Open Access. After publication in volume 43, issue 3, page 197–203 authors decided that the article be Open Choice to make the article an open access publication.
AB - The article A Cross‑Sectional Study of Tampering in Xtampza ER, an Abuse‑Deterrent Formulation of an Extended‑Release Opioid, in a Treatment Center Population, written by Jennifer Jewell, Joshua Black, Matthew Ellis, Heather Olsen, Janetta Iwanicki and Richard Dart, was originally published Online First without Open Access. After publication in volume 43, issue 3, page 197–203 authors decided that the article be Open Choice to make the article an open access publication.
UR - http://www.scopus.com/inward/record.url?scp=85152401870&partnerID=8YFLogxK
U2 - 10.1007/s40261-023-01259-6
DO - 10.1007/s40261-023-01259-6
M3 - Comment/debate
C2 - 37040042
AN - SCOPUS:85152401870
SN - 1173-2563
VL - 43
SP - 379
JO - Clinical Drug Investigation
JF - Clinical Drug Investigation
IS - 5
ER -